Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-11 Sale |
2025-04-15 8:33 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
15,319 | $12.19 | $186,803 | 862,289 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 9:44 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
18,333 | $9.0592 | $166,082 | 877,608 (Direct) |
View |
| 2024-10-11 Sale |
2024-10-15 4:21 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
15,271 | $13.52 | $206,433 | 895,941 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-12 4:36 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
15,746 | $13.34 | $210,075 | 911,212 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-20 5:44 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
49,313 | $12.01 | $592,022 | 926,958 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-14 6:15 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
72,797 | $12.7 | $924,203 | 976,271 (Direct) |
View |
| 2023-11-22 Purchase |
2023-11-27 4:01 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
4,250 | $5.9661 | $25,356 | 1,049,068 (Direct) |
View |
| 2023-09-06 Purchase |
2023-09-08 08:49 am |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,250 | $12.08 | $27,180 | 1,044,818 (Direct) |
View |
| 2023-08-17 Purchase |
2023-08-21 4:03 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,250 | $12.1 | $27,225 | 1,042,568 (Direct) |
View |
| 2023-08-11 Purchase |
2023-08-11 7:11 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,000 | $12.89 | $25,780 | 1,040,318 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-24 6:58 pm |
N/A 2035-02-13 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
570,000 | $0 | 570,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:26 pm |
N/A 2034-02-13 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-21 6:48 pm |
N/A 2033-03-17 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
99,800 | $0 | 99,800 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:01 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
250,046 | $0 | 250,046 (Direct) |
View |
Ownership |
2023-02-09 7:52 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
0 | $0 | 1,062,400 (Direct) |
View |